Literature DB >> 33494589

Medical treatment of thyrotoxicosis.

Lorenzo Scappaticcio1, Giuseppe Bellastella2,3, Maria I Maiorino2,3, Luca Giovanella4,5, Katherine Esposito3,6.   

Abstract

Medical treatment is the primary therapeutic option for thyrotoxicosis/hyperthyroidism. Two groups of causes of thyrotoxicosis (i.e. thyrotoxicosis with hyperthyroidism and thyrotoxicosis without hyperthyroidism) need to be considered for therapeutic reasons. Herein we provide an updated review on the role of conventional medical therapies (i.e. β-blockers, antithyroid drugs [ATDs], corticosteroids, inorganic iodide, perchlorate, cholecystographic agents, lithium, cholestyramine) in the main causes of thyrotoxicosis, starting from the rationale subtending their clinical application.

Entities:  

Year:  2021        PMID: 33494589     DOI: 10.23736/S1824-4785.21.03334-3

Source DB:  PubMed          Journal:  Q J Nucl Med Mol Imaging        ISSN: 1824-4785            Impact factor:   2.346


  2 in total

1.  The prognostic value of thyroid-stimulating immunoglobulin in the management of Graves' disease.

Authors:  Yulin Zhou; Mengxi Zhou; Yicheng Qi; Weiqing Wang; Xinxin Chen; Shu Wang
Journal:  Ther Adv Endocrinol Metab       Date:  2021-09-28       Impact factor: 3.565

2.  Thyroid surgery during the COVID-19 pandemic: results from a systematic review.

Authors:  L Scappaticcio; M I Maiorino; S Iorio; C Camponovo; A Piccardo; G Bellastella; G Docimo; K Esposito; P Trimboli
Journal:  J Endocrinol Invest       Date:  2021-07-19       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.